HomeGenetic InsightsSmoking status & the GeneSight test Smoking status & the GeneSight test September 19, 2023Genetic Insights In August 2023, Myriad Genetics enhanced the GeneSight Psychotropic test to include information on how a patient’s smoking status may impact their body’s metabolism of certain mental health medications. The GeneSight Psychotropic test will now provide non-smoking and smoking results when applicable. These updates were based on a comprehensive analysis of peer-reviewed literature and our continued commitment to provide clinicians and patients with genetic insights to help inform treatment decisions. The prevalence of smoking cigarettes in patients who have depression or anxiety is higher than in the general population.1 Daily or near-daily use of marijuana is two times higher in individuals with depression compared to those without it.2 What’s considered “smoking”? On the GeneSight report, smoking is defined as the daily inhalation of burning plant material, such as cigarettes and marijuana. The definition excludes vaping and e-cigarettes. How does smoking affect my GeneSight test results? In addition to genetics, environmental factors, such as smoking, can cause a gene-drug-environment interaction, which may affect how certain medications are broken down in the body. The CYP1A2 gene encodes for the CYP1A2 pharmacokinetic enzyme that is involved in the metabolism (or breakdown) of various medications, including certain antidepressants, anxiolytic and hypnotics, and antipsychotics. Some patients have a highly inducible genetic variant in the CYP1A2 gene, and this variant in the presence of smoking can result in increased CYP1A2 activity. This increase in CYP1A2 activity may result in faster than normal breakdown of certain mental health medications found on the GeneSight report. For these patients, the categorization and information provided on the GeneSight report for certain medications can be affected by smoking status. See this Genetic Insight for more information on rates of metabolism. What is the prevalence of the CYP1A2 variant? Data has shown that about 91% of patients have a CYP1A2 variant that is highly inducible by smoking. The presence of this variant in those who smoke may cause certain medications metabolized by CYP1A2 to be broken down more quickly than normal. For the roughly nine percent of patients who don’t have the CYP1A2 highly inducible variant, smoking is not expected to impact how quickly these medications are metabolized through CYP1A2. How many medications are potentially affected by smoking? Roughly a third of all medications on the GeneSight Psychotropic report are identified as having CYP1A2 involvement. These 23 medications include several antidepressants, anxiolytics and hypnotics, and antipsychotics. How does smoking status appear on the GeneSight report? The GeneSight report has been modified to include new labeling about smoking status near the top of the impacted medication pages for patients with the highly inducible CYP1A2 variant (91% of the population). For these patients, the GeneSight report will include non-smoker and smoker pages of results for antidepressants, anxiolytics and hypnotics, and antipsychotics. In addition, medications impacted by smoking status are labeled with clinical consideration number 7, which indicates that smoking status changes the results of the specific medication. Accordingly, clinicians are referred to use the section labeled “Smokers” if the patient smokes. Medications in two other classes on the report – mood stabilizers and stimulants and non-stimulants – will not have separate non-smoker and smoker pages, since CYP1A2 is not predicted to influence the breakdown of these medications. Patients who do not have the highly inducible CYP1A2 variant will not receive separate non-smoker and smoker results. For these patients, their reports will note that the test results provided are for both non-smokers and smokers since the patient does not have the highly inducible CYP1A2 variant. For more information on how to interpret GeneSight report, please read this Genetic Insight. How will my clinician use the test results? Your clinician may use the results of the GeneSight Psychotropic test to help inform medication selection and treatment decisions, based on your unique genetic makeup. Test results could be especially helpful for patients who have experienced side effects or have failed to respond to certain medications. For more information on the GeneSight test, email us at medinfo@myriad.com, or contact us at 855.891.9415. This document is for educational purposes related to pharmacogenomics and personalized medicine only and should not be considered medical advice. The information is based on scientific opinion from industry experts and is intended to provide additional information to healthcare providers. These materials may be changed, improved, or updated without notice. Myriad Genetics is not responsible for any errors or omissions contained in third-party content. We encourage you to contact us for specific scientific advice regarding our GeneSight® tests. You may print a copy of this document for your own personal noncommercial use. You may not copy any part of this document for any other purpose, and you may not modify any part of this document without the permission of Myriad Genetics. All rights reserved. 1 Cornelius, M.E. et al. (2022). “Tobacco Product Use Among Adults- United States, 2020.” MMWR Morb Mortal Wkly Rep, 71 2 Dai, H. and K.P. Richter. (2019). “A National Survey of Marijuana Use Among US Adults with Medical Conditions.” JAMA Network Open, 2(9):e1911936 Patient Movement as Medicine: Solutions for Anxiety Moving forward. It sounds like a nice idea, especially when you’re feeling stuck deep in the throes of an anxiety spiral. But it turns out that physically m... Read more Patient Weight-Loss Drugs and Mental Health: What You Need to Know New medications for weight loss seem to be flying off pharmacy shelves these days. But could they be linked to mental health conditions? Researchers are ... Read more Patient 3 million patients (and counting!) have now taken the GeneSight test! We’re thrilled to share that 3 million patients (and counting!) have now taken the GeneSight test! We're so grateful to the dedicated healthcare providers who... Read more Patient The Model Minority Myth and Mental Health The model minority myth stereotypes one cultural group, typically Asian Americans, as “intelligent, hard-working, and diligent and therefore more academically, ... Read more Healthcare Provider How Clinicians Can Help Support Their Patients Who Are Being Bullied How Clinicians Can Help Support Their Patients Who Are Being Bullied Acts of bullying can cause feelings of fear, loneliness and sadness, as well as depressi... Read more Patient Cyberbullying: Unique Challenges and Impacts ‘We lost our daughter to cyberbullying.’ McKenna Brown was an accomplished hockey player and scholar, known for her kindness, when she became the target of int... Read more Going Beyond Green, Yellow, Red on the GeneSight Report This blog summarizes key points discussed during the March 2024 GeneSight® Engage webinar Participants: Bernie Ranchero, MD, MS, MBA, medical direc... Read more Healthcare Provider Top 5 Reasons Patients Stop Their Mood Disorder Treatment Mood disorder treatment for depression can be challenging – and patients may become frustrated when treatments don’t work. In fact, when people with depres... Read more Patient The Impact of Gratitude on Depression and Anxiety “Say ‘Thank you,” a mother reminds her young kiddo. “T.G.I.F.!” we cheer at the end of a long week. We know it’s important to be thankful. But do we ... Read more Patient The Silent Thief: The 5 Things Depression Can Steal “Depression is a thief,” writes Abhinav Chaurasia, a marketing automation specialist in an essay on LinkedIn. “It steals your joy, your motivation, and your abi... Read more Patient How to Talk to Your Doctor about Anxiety Medication “When I was 27, I felt bad all the time,” writes Joanna Goddard on the popular Cup of Jo blog. She describes her initial experience with anxiety in detail. ... Read more Healthcare Provider Building Trust by Reducing Bias: The GeneSight Test as a Tool for Mental Health Equity This blog summarizes key points discussed during Myriad Mental Health’s July 2022 Webinar: Building Trust by Reducing Bias: The GeneSight Test as a Tool for Men... Read more Patient Anxiety and older adults: What to look for and how to help “It’s not how old you are. It’s how you are, old.” - French author Jules Renard Mental health is important at every age. But when people experience an a... Read more Patient Adult ADHD: Symptoms, treatment, where to start Many people may incorrectly think ADHD, or attention-deficit/hyperactivity disorder, only impacts children. After all, according to the Centers for Disease C... Read more Healthcare Provider It’s time to talk suicide: addressing stigma around a difficult topic Trigger Warning: This webinar discusses suicide. If you or someone you know has suicidal thoughts, please call the National Suicide Prevention Lifeline at 988. ... Read more Patient Stress Relief Methods for Family Caregivers Caring for a loved one can be a rewarding and meaningful experience. However, the day in and day out of taking care of someone who is unwell also can be challen... Read more Healthcare Provider Healthcare Professional Burnout and Links to Depression When Dr. Lorna Breen, an ER doc in Manhattan, died by suicide in April 2020, it opened up a public discussion about the burdens faced by healthcare professi... Read more Healthcare Provider Antidepressant Withdrawal or Depression Reoccurrence? What Healthcare Providers Should Know People who stop taking antidepressants may do so for many reasons: they may feel like it isn’t working, may feel unable to cope with side effects, or may not fe... Read more Learn more Learn more about GeneSight How to talk to your provider View our clinical studies
Patient Movement as Medicine: Solutions for Anxiety Moving forward. It sounds like a nice idea, especially when you’re feeling stuck deep in the throes of an anxiety spiral. But it turns out that physically m... Read more
Patient Weight-Loss Drugs and Mental Health: What You Need to Know New medications for weight loss seem to be flying off pharmacy shelves these days. But could they be linked to mental health conditions? Researchers are ... Read more
Patient 3 million patients (and counting!) have now taken the GeneSight test! We’re thrilled to share that 3 million patients (and counting!) have now taken the GeneSight test! We're so grateful to the dedicated healthcare providers who... Read more
Patient The Model Minority Myth and Mental Health The model minority myth stereotypes one cultural group, typically Asian Americans, as “intelligent, hard-working, and diligent and therefore more academically, ... Read more
Healthcare Provider How Clinicians Can Help Support Their Patients Who Are Being Bullied How Clinicians Can Help Support Their Patients Who Are Being Bullied Acts of bullying can cause feelings of fear, loneliness and sadness, as well as depressi... Read more
Patient Cyberbullying: Unique Challenges and Impacts ‘We lost our daughter to cyberbullying.’ McKenna Brown was an accomplished hockey player and scholar, known for her kindness, when she became the target of int... Read more
Going Beyond Green, Yellow, Red on the GeneSight Report This blog summarizes key points discussed during the March 2024 GeneSight® Engage webinar Participants: Bernie Ranchero, MD, MS, MBA, medical direc... Read more
Healthcare Provider Top 5 Reasons Patients Stop Their Mood Disorder Treatment Mood disorder treatment for depression can be challenging – and patients may become frustrated when treatments don’t work. In fact, when people with depres... Read more
Patient The Impact of Gratitude on Depression and Anxiety “Say ‘Thank you,” a mother reminds her young kiddo. “T.G.I.F.!” we cheer at the end of a long week. We know it’s important to be thankful. But do we ... Read more
Patient The Silent Thief: The 5 Things Depression Can Steal “Depression is a thief,” writes Abhinav Chaurasia, a marketing automation specialist in an essay on LinkedIn. “It steals your joy, your motivation, and your abi... Read more
Patient How to Talk to Your Doctor about Anxiety Medication “When I was 27, I felt bad all the time,” writes Joanna Goddard on the popular Cup of Jo blog. She describes her initial experience with anxiety in detail. ... Read more
Healthcare Provider Building Trust by Reducing Bias: The GeneSight Test as a Tool for Mental Health Equity This blog summarizes key points discussed during Myriad Mental Health’s July 2022 Webinar: Building Trust by Reducing Bias: The GeneSight Test as a Tool for Men... Read more
Patient Anxiety and older adults: What to look for and how to help “It’s not how old you are. It’s how you are, old.” - French author Jules Renard Mental health is important at every age. But when people experience an a... Read more
Patient Adult ADHD: Symptoms, treatment, where to start Many people may incorrectly think ADHD, or attention-deficit/hyperactivity disorder, only impacts children. After all, according to the Centers for Disease C... Read more
Healthcare Provider It’s time to talk suicide: addressing stigma around a difficult topic Trigger Warning: This webinar discusses suicide. If you or someone you know has suicidal thoughts, please call the National Suicide Prevention Lifeline at 988. ... Read more
Patient Stress Relief Methods for Family Caregivers Caring for a loved one can be a rewarding and meaningful experience. However, the day in and day out of taking care of someone who is unwell also can be challen... Read more
Healthcare Provider Healthcare Professional Burnout and Links to Depression When Dr. Lorna Breen, an ER doc in Manhattan, died by suicide in April 2020, it opened up a public discussion about the burdens faced by healthcare professi... Read more
Healthcare Provider Antidepressant Withdrawal or Depression Reoccurrence? What Healthcare Providers Should Know People who stop taking antidepressants may do so for many reasons: they may feel like it isn’t working, may feel unable to cope with side effects, or may not fe... Read more